Cargando…
Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756217/ https://www.ncbi.nlm.nih.gov/pubmed/30872782 http://dx.doi.org/10.1038/s41375-019-0443-7 |
| _version_ | 1783453363217629184 |
|---|---|
| author | Janssen, L. Frambach, S. J. C. M. Allard, N. A. E. Hopman, M. T. E. Schirris, T. J. J. Voermans, N. C. Rodenburg, R. J. Blijlevens, N. M. A. Timmers, S. |
| author_facet | Janssen, L. Frambach, S. J. C. M. Allard, N. A. E. Hopman, M. T. E. Schirris, T. J. J. Voermans, N. C. Rodenburg, R. J. Blijlevens, N. M. A. Timmers, S. |
| author_sort | Janssen, L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6756217 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67562172019-09-27 Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia Janssen, L. Frambach, S. J. C. M. Allard, N. A. E. Hopman, M. T. E. Schirris, T. J. J. Voermans, N. C. Rodenburg, R. J. Blijlevens, N. M. A. Timmers, S. Leukemia Letter Nature Publishing Group UK 2019-03-14 2019 /pmc/articles/PMC6756217/ /pubmed/30872782 http://dx.doi.org/10.1038/s41375-019-0443-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Janssen, L. Frambach, S. J. C. M. Allard, N. A. E. Hopman, M. T. E. Schirris, T. J. J. Voermans, N. C. Rodenburg, R. J. Blijlevens, N. M. A. Timmers, S. Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| title | Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| title_full | Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| title_fullStr | Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| title_full_unstemmed | Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| title_short | Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| title_sort | skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756217/ https://www.ncbi.nlm.nih.gov/pubmed/30872782 http://dx.doi.org/10.1038/s41375-019-0443-7 |
| work_keys_str_mv | AT janssenl skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT frambachsjcm skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT allardnae skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT hopmanmte skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT schirristjj skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT voermansnc skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT rodenburgrj skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT blijlevensnma skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia AT timmerss skeletalmuscletoxicityassociatedwithtyrosinekinaseinhibitortherapyinpatientswithchronicmyeloidleukemia |